Blackrock’s Sending THIS Crypto Higher on Purpose

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

Stanley Trotman, Jr. Biography and Net Worth

Director of Forian

Stanley S. Trotman is on the board of Ascend Health Corp. and Forian, Inc.

Mr. Trotman previously held the position of Head-Health Care Group at Drexel Burnham Lambert, Inc., Venture Partner at Sunrock Equity Partners LLC, Managing Director at PaineWebber, Inc. and Managing Director-Health Care Group at UBS Financial Services, Inc.

He received an undergraduate degree from Yale University and an MBA from Columbia Business School.

What is Stanley S. Trotman, Jr.'s net worth?: The estimated net worth of Stanley S. Trotman, Jr. is at least $281,126.56 as of May 16th, 2023. Mr. Trotman, Jr. owns 135,157 shares of Forian stock worth more than $281,127 as of November 21st. This net worth estimate does not reflect any other assets that Mr. Trotman, Jr. may own. Learn More about Stanley S. Trotman, Jr.'s net worth.
How do I contact Stanley S. Trotman, Jr.?: The corporate mailing address for Mr. Trotman, Jr. and other Forian executives is 41 University Drive, Suite 400, Newtown, PA 18940, United States. Forian can also be reached via phone at +17203285372. Learn More on Stanley S. Trotman, Jr.'s contact information.
Has Stanley S. Trotman, Jr. been buying or selling shares of Forian?: Stanley S. Trotman, Jr. has not been actively trading shares of Forian during the last ninety days. Most recently, on Tuesday, May 16th, Stanley S. Trotman, Jr. bought 7,657 shares of Forian stock. The stock was acquired at an average cost of $2.40 per share, with a total value of $18,376.80. Following the completion of the transaction, the director now directly owns 135,157 shares of the company's stock, valued at $324,376.80. Learn More on Stanley S. Trotman, Jr.'s trading history.
Who are Forian's active insiders?: Forian's insider roster includes Jennifer Hajj (Director), Stanley Trotman, Jr. (Director), and Martin Wygod (Director). Learn More on Forian's active insiders.

Stanley S. Trotman, Jr. Insider Trading History at Forian

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/16/2023	Buy	7,657	$2.40	$18,376.80	135,157
1/7/2022	Buy	2,500	$7.91	$19,775.00
1/5/2022	Buy	5,000	$8.04	$40,200.00
12/22/2021	Buy	7,524	$8.56	$64,405.44
3/19/2021	Buy	2,612	$12.63	$32,989.56	57,232
3/17/2021	Buy	11,457	$12.32	$141,150.24	48,633
3/15/2021	Buy	4,333	$12.42	$53,815.86	48,633
3/12/2021	Buy	7,202	$12.32	$88,728.64	36,998
3/10/2021	Buy	13,241	$11.93	$157,965.13	36,998

Stanley S. Trotman, Jr. Buying and Selling Activity at Forian

Forian Company Overview

Forian Inc. provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions. The company's subscription and services-based solutions cover the life sciences, pharma services, and healthcare payer and provider industries. Forian Inc. was founded in 2020 and is headquartered in Newtown, Pennsylvania.

Today's Range

Now: $2.08

$2.04

$2.08

50 Day Range

MA: $2.12

$2.00

$2.31

2 Week Range

Now: $2.08

$1.98

$4.15

Volume

1,665 shs

Average Volume

16,649 shs

Market Capitalization

$64.51 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.09

New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar

From Darwin | Ad

As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.

👉 Click here to access your FREE report now!